Performance of HbA1c As an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2012 Jun 16

PMID 22699293

Citations 22

Authors

Kendra Vehik

David Cuthbertson

David Boulware

Craig A Beam

Henry Rodriguez

Laurent Legault

Mila Hyytinen

Marian J Rewers

Desmond A Schatz

Jeffrey P Krischer

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to evaluate HbA(1c) as an alternative criterion for impaired glucose tolerance (IGT) or type 1 diabetes (T1D) in high-risk subjects <21 years of age.

Research Design And Methods: Subjects <21 years of age who participated in the prospective DPT-1, TEDDY, TRIGR, and Type 1 Diabetes TrialNet Natural History (TrialNet) studies and had an HbA(1c) within 90 days of an OGTT with a 2-h plasma glucose (2-hPG) measure were included. An OGTT of 140-199 mg/dL defined IGT, and an OGTT with 2-hPG ≥200 mg/dL or fasting plasma glucose ≥126 mg/dL defined diabetes. HbA(1c) ≥5.7% defined IGT, and HbA(1c) ≥ 6.5% defined diabetes. Receiver-operating characteristic curve analysis was used to assess diagnostic accuracy of HbA(1c) compared with OGTT.

Results: There were 587 subjects from DPT-1, 884 from TrialNet, 91 from TEDDY, and 420 from TRIGR. As an indicator for IGT, HbA(1c) sensitivity was very low across the studies (8-42%), and specificity was variable (64-95%). With HbA(1c) ≥6.5% threshold used for T1D diagnosis, the sensitivity was very low and specificity was high (sensitivity and specificity: DPT-1 24 and 98%, TrialNet 28 and 99%, TEDDY 34 and 98%, and TRIGR 33 and 99%, respectively). The positive predictive value of HbA(1c) ≥6.5% for the development of T1D was variable (50-94%) across the four studies.

Conclusions: HbA(1c) ≥6.5% is a specific but not sensitive early indicator for T1D in high-risk subjects <21 years of age diagnosed by OGTT or asymptomatic hyperglycemia. Redefining the HbA(1c) threshold is recommended if used as an alternative criterion in diagnosing T1D.

Citing Articles

Data from a multi-year targeted proteomics study of a longitudinal birth cohort of type 1 diabetes.

Bramer L, Nakayasu E, Flores J, Van Eyk J, MacCoss M, Parikh H Sci Data. 2025; 12(1):112.

PMID: 39833216 PMC: 11747092. DOI: 10.1038/s41597-024-04249-1.

ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes.

Haller M, Bell K, Besser R, Casteels K, Couper J, Craig M Horm Res Paediatr. 2024; 97(6):529-545.

PMID: 39662065 PMC: 11854978. DOI: 10.1159/000543035.

Discordance between Glucose Management Indicator and Glycated Hemoglobin in a Pediatric Cohort with Type 1 Diabetes: A Real-World Study.

Foti Randazzese S, Bombaci B, Costantino S, Giorgianni Y, Lombardo F, Salzano G Children (Basel). 2024; 11(2).

PMID: 38397323 PMC: 10887365. DOI: 10.3390/children11020210.

Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity.

Nakayasu E, Bramer L, Ansong C, Schepmoes A, Fillmore T, Gritsenko M Cell Rep Med. 2023; 4(7):101093.

PMID: 37390828 PMC: 10394168. DOI: 10.1016/j.xcrm.2023.101093.

Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.

Vehik K, Boulware D, Killian M, Rewers M, McIndoe R, Toppari J Diabetes Care. 2022; 45(10):2342-2349.

PMID: 36150054 PMC: 9587339. DOI: 10.2337/dc22-0828.

References

. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7):1327-34. PMC: 2699715. DOI: 10.2337/dc09-9033. View

Youden W . Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. DOI: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. View

Harrell Jr F, Califf R, Pryor D, Lee K, Rosati R . Evaluating the yield of medical tests. JAMA. 1982; 247(18):2543-6. View

Bennett C, Guo M, Dharmage S . HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 2007; 24(4):333-43. DOI: 10.1111/j.1464-5491.2007.02106.x. View

. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci. 2009; 1150:1-13. PMC: 2886800. DOI: 10.1196/annals.1447.062. View

. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7):1183-97. DOI: 10.2337/diacare.20.7.1183. View

Ehehalt S, Gauger N, Blumenstock G, Feldhahn L, Scheffner T, Schweizer R . Hemoglobin A1c is a reliable criterion for diagnosing type 1 diabetes in childhood and adolescence. Pediatr Diabetes. 2010; 11(7):446-9. DOI: 10.1111/j.1399-5448.2009.00633.x. View

. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002; 346(22):1685-91. DOI: 10.1056/NEJMoa012350. View

Elding Larsson H, Vehik K, Bell R, Dabelea D, Dolan L, Pihoker C . Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care. 2011; 34(11):2347-52. PMC: 3198296. DOI: 10.2337/dc11-1026. View

10.

Saudek C, Herman W, Sacks D, Bergenstal R, Edelman D, Davidson M . A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008; 93(7):2447-53. DOI: 10.1210/jc.2007-2174. View

11.

Lee J, Wu E, Tarini B, Herman W, Yoon E . Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?. J Pediatr. 2011; 158(6):947-952.e1-3. PMC: 3210198. DOI: 10.1016/j.jpeds.2010.11.026. View

12.

Stene L, Barriga K, Hoffman M, Kean J, Klingensmith G, Norris J . Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes. 2006; 7(5):247-53. DOI: 10.1111/j.1399-5448.2006.00198.x. View

13.

Cheng P, Neugaard B, Foulis P, Conlin P . Hemoglobin A1c as a predictor of incident diabetes. Diabetes Care. 2011; 34(3):610-5. PMC: 3041192. DOI: 10.2337/dc10-0625. View

14.

Hoelzel W, Weykamp C, Jeppsson J, Miedema K, Barr J, Goodall I . IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem. 2004; 50(1):166-74. DOI: 10.1373/clinchem.2003.024802. View

15.

Holmes W . A short, psychiatric, case-finding measure for HIV seropositive outpatients: performance characteristics of the 5-item mental health subscale of the SF-20 in a male, seropositive sample. Med Care. 1998; 36(2):237-43. DOI: 10.1097/00005650-199802000-00012. View

16.

Akerblom H, Krischer J, Virtanen S, Berseth C, Becker D, Dupre J . The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia. 2010; 54(3):627-33. PMC: 3034039. DOI: 10.1007/s00125-010-1964-9. View

17.

Mahon J, Sosenko J, Rafkin-Mervis L, Krause-Steinrauf H, Lachin J, Thompson C . The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes. 2008; 10(2):97-104. DOI: 10.1111/j.1399-5448.2008.00464.x. View

18.

Sacks D . A1C versus glucose testing: a comparison. Diabetes Care. 2011; 34(2):518-23. PMC: 3024379. DOI: 10.2337/dc10-1546. View